More on life-threatening asthma and salmeterol [11]

New England Journal of Medicine

Volumn 355, Issue 20, 2006, Pages 2157-2158

  Lawyer, Matthew C ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; SALMETEROL; UNCLASSIFIED DRUG; XINAFOATE;

ASTHMA; DISEASE SEVERITY; HAZARD ASSESSMENT; HUMAN; INHALER; LETTER; LOGISTIC REGRESSION ANALYSIS; MOLECULAR WEIGHT; PRIORITY JOURNAL; RECURRENT DISEASE;

ADMINISTRATION, INHALATION; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; HUMANS; LOGISTIC MODELS; OCCUPATIONAL DISEASES;

EID: 33751018836     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc062585     Document Type: Letter

References (4)

1. Weinberger M, Abu-Hasan M. Life-threatening asthma during treatment with salmeterol. N Engl J Med 2006;355:852-3.
2. Chan-Yeung M, Malo J-L. Occupational asthma. N Engl J Med 1995;333:107-12.
3. Jarvis J, Seed MJ, Elton R, Sawyer L, Agius R. Relationship between chemical structure and the occupational asthma hazard of low molecular weight organic compounds. Occup Environ Med 2005;62:243-50.
4. Chemical Asthma Hazard Assessment Program. (Accessed October 26, 2006, at http://homepages.ed.ac.uk/jjarvis/research/hazassess/hazassess.html.)